Global Specialty Drug Distribution Market Growth (Status and Outlook) 2023-2029

Global Specialty Drug Distribution Market Growth (Status and Outlook) 2023-2029

Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.

It is common for each specialty pharmaceutical product to have its own go-to-market strategy. Because of the unique specialty drug product specifications, therapy regimens, drug product handling, storage and transportation requirements, pricing, reimbursement and other factors, drug distribution channels and methodologies are impacted and must be considered prior to product launch. Specialty drugs do not necessarily flow directly downstream to the patient via the dispensing pharmacist. Pharmacy benefit-controlled specialty drugs can be more tightly controlled in real time, improving the payers’ ability to track utilization.

Specialty drugs are produced by specialty pharmaceutical manufacturers then sent to specialty distributors or large specialty pharmacies. From there, they may be distributed directly to patients or be sent to retail pharmacies. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.

LPI (LP Information)' newest research report, the “Specialty Drug Distribution Industry Forecast” looks at past sales and reviews total world Specialty Drug Distribution sales in 2022, providing a comprehensive analysis by region and market sector of projected Specialty Drug Distribution sales for 2023 through 2029. With Specialty Drug Distribution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Specialty Drug Distribution industry.

This Insight Report provides a comprehensive analysis of the global Specialty Drug Distribution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Specialty Drug Distribution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Specialty Drug Distribution market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Specialty Drug Distribution and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Specialty Drug Distribution.

The global Specialty Drug Distribution market size is projected to grow from US$ 261790 million in 2022 to US$ 543380 million in 2029; it is expected to grow at a CAGR of 11.0% from 2023 to 2029.

Global Specialty Drug Distribution key players include Amerisource, Mckesson, Cardinal Health, PHOENIX group, etc.

North America is the largest market, with a share about 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.

In terms of product, Oncology is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital and Clinics, followed by Pharmacy, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Specialty Drug Distribution market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

Oncology

Rheumatoid Arthritis

Multiple Sclerosis

Hemophilia

Others

Segmentation by application

Hospital and Clinic

Pharmacy

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

AmerisourceBergen

Mckesson

Cardinal Health

Phoenix

Medipal Holdings

Alliance Healthcare

Sinopharm

Express Scripts

Shanghai Pharma

Anda

Jointown

Max Pharma

Please note: The report will take approximately 2 business days to prepare and deliver.